Bristol-Myers gets FDA priority review for children’s bipolar …
CNBC - NEW YORK (Thomson Financial) - Bristol-Myers Squibb Co. and partner Otsuka Pharmaceutical Co. Thursday said the Food and Drug Administration has granted a priority review of the supplemental new drug application for atypical anti-psychotic drug …